0000878088-12-000082.txt : 20121012 0000878088-12-000082.hdr.sgml : 20121012 20121012082951 ACCESSION NUMBER: 0000878088-12-000082 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20121012 DATE AS OF CHANGE: 20121012 EFFECTIVENESS DATE: 20121012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-20605 FILM NUMBER: 121141062 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 15-12G 1 form15oct2012.htm FORM 15-12G Converted by EDGARwiz

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR

SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-10827

PAR PHARMACEUTICAL COMPANIES, INC.

(Exact name of registrant as specified in its charter)

300 Tice Boulevard

Woodcliff Lake, NJ 07677

(201) 802-4000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

COMMON STOCK, PAR VALUE $.01 PER SHARE

 (Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 






 

 

 

 

 

Rule 12g-4(a)(1)

  

x

 

  

Rule 12g-4(a)(2)

  

¨

 

  

Rule 12h-3(b)(1)(i)

  

x

 

  

Rule 12h-3(b)(1)(ii)

  

¨

 

  

Rule 15d-6

  

¨

 

  

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Par Pharmaceutical Companies, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 








 


 


 






Date: October 12, 2012

 


 

By:

 

/s/ Thomas J. Haughey


 


 


 

Name: Thomas J. Haughey

Title: President